News for QTNT Stock

Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market Quotient Limited Announces Reverse Stock Split Effective Today Quotient Limited Announces Intent to Effect Reverse Stock Split Sannova Appoints Jason Apter as CEO and Stephen Unger as CFO Quotient Limited Selected to Join the World Economic Forum New Champions Community Quotient Limited Expands MosaiQ Innovator’s Circle to Empower Patient Care and Laboratory Efficiencies Quotient Limited Provides First Quarter Fiscal 2023 Results and Business Update Quotient Limited to Report First Quarter Fiscal 2023 Financial Results and Host Conference Call on August 9th Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu Quotient Limited Announces Equity Awards Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares and Pre-Funded Warrants Quotient Limited Announces Pricing of Underwritten Offering Quotient Limited Provides Fourth Quarter Fiscal 2022 Results and Business Update Quotient Limited Announces Proposed Amendments to Senior Secured Notes Quotient Limited Announces Proposed Underwritten Offering Quotient Limited Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials Quotient Limited to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution Quotient Limited Announces Appointment of New Board Member Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray Quotient Limited to Participate in the Cowen 42nd Annual Health Care Conference Quotient Limited Reports Third Quarter Fiscal 2022 Results and Provides Business Update Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Quotient Limited Announces Equity Awards Quotient Limited Provides MosaiQ Regulatory & Commercial Update Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call Quotient Limited Launches Scientific Advisory Board and Research Programs Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer Quotient Limited Announces Equity Awards Quotient Limited Provides Second Quarter Fiscal 2022 Results Quotient Limited to Participate in the Jefferies London Healthcare Conference Quotient Limited Provides Business Update and Delays Releasing Second Quarter Fiscal 2022 Results Quotient Limited to Report Second Quarter Fiscal Year 2022 Financial Results and Host Conference Call Quotient Limited Announces receipt of Note Holders Consents to Indenture Amendments That Extend Maturity, Defer Principal Payments on 12% Senior Secured Notes Quotient Limited Announces Appointment of Chief Financial Officer Quotient Limited Announces Appointment of Chief Commercial Officer Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray Quotient Limited Announces Christian Albrich as Chief People Officer Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update Quotient Limited Announces Equity Awards Quotient Limited to Report First Quarter Fiscal Year 2022 Financial Results and Host Conference Call Quotient Limited Announces Departure of Chief Financial Officer, Peter Buhler Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update Quotient Limited to Participate in Upcoming Investor Conferences Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call Quotient Limited Announces New $95 Million Financing Led by Highbridge MosaiQ by Quotient Wins Prestigious Red Dot Design Award Quotient Limited Reports Further Enhanced Multimodal Capabilities of the MosaiQ Technology Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test Quotient Limited Announces Equity Awards Quotient Limited to Participate in the Cowen 41st Annual Healthcare Conference Quotient Limited Announces Manuel Mendez as Chief Executive Officer Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference Quotient Limited Reports Third Quarter Fiscal 2021 Results and Business Update Quotient Limited to Report Third Quarter 2021 Financial Results and Host Conference Call Quotient Limited Wins 2021 BIG Innovation Award Quotient Limited Announces Departure of Chief Operating Officer Quotient Limited Provides Status Update on the Initial SDS Microarray and MosaiQ Instrument for the US Market Quotient Limited Announces MosaiQ™ Expanded IH EU Field Trial Performance Data Quotient Limited to Participate in Two Upcoming Conferences Quotient Limited Reports Second Quarter Fiscal 2021 Results and Business Update Quotient Limited to Report Second Quarter 2021 Financial Results and Host Conference Call Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares Quotient Limited Announces Upsize and Pricing of Underwritten Offering of Ordinary Shares Quotient Limited and Ortho Clinical Diagnostics Settle Arbitration and Sign Binding Letter of Intent Covering Patient Transfusion Diagnostics Bloodworks Northwest Now Tests All Donors for COVID-19 Antibodies Looking for More Qualified Convalescent Plasma Donors Quotient Announces Appointment of Two New Board Members Quotient Limited Provides Update on COVID-19 Antibody Test Progress, Other Key Developments and Fourth Quarter and Full Year Fiscal 2020 Results Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray Quotient Limited to Publish Quarterly Investor Presentation Quotient Announces Equity Awards Quotient Limited Reports Impressive Results from an Independent SARS-CoV-2 Antibody Detection Study Conducted in Spain Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference Quotient Limited Reports First Quarter Fiscal 2021 Results and Business Update